Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...

Alethio Therapeutics Launches with New CEO and Chair to Advance Two Targeted Medicines for Myeloproliferative Neoplasms (Chronic Blood Cancers) ...

An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain.

Autolus Therapeutics plc (NASDAQ: AUTL) is one of the best stocks under $5 with highest upside potential. Autolus ...

The global car t-cell therapy market size is predicted to increase from USD 7.64 billion in 2025 and is anticipated to be ...

New triple therapy reprograms cancer cell death, helping the immune system destroy tumors. The goal of immunotherapy is to activate a patient’s own immune system to target and destroy tumor cells. In ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under ...

PANoptosis, an emerging concept in immunology, refers to a form of programmed cell death that integrates various signaling ...

An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...

Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...

A recent trial reveals lenvatinib plus everolimus significantly improves progression-free survival in metastatic renal cell ...

Healing a wound without leaving a scar is something we could all do while in the womb. But unlocking this ability after birth ...